Publications by authors named "J Mejia Ortega"

Background: Magnetic resonance imaging (MRI) has been very useful in evaluating brain atrophy related to Alzheimer's Disease (AD), so it is important to have scales that allow objective evaluation specifically of parietal atrophy. The objective of this study was to develop and validate a modified visual scale for the assessment of parietal atrophy (APM Scale) by brain MRI in a single slice (axial T2-FLAIR), with focus on the measurement of the posterior cingulate sulcus to differentiate between Mild Cognitive Impairment (MCI), AD and other forms of dementia (OD not AD).

Method: retrospective validation study carried out in a memory clinic of a tertiary hospital in Mexico City, in a period from March 2015 to June 2023.

View Article and Find Full Text PDF

In the rapidly growing field of psychedelic research, psilocybin (and active metabolite psilocin) has been proposed as a promising candidate in the search for novel treatments for neuropsychiatric disorders. Clinical trials have revealed that psilocybin has a large, rapid, and persistent effect in the improvement of symptoms of depression and anxiety. The safety profile is considered favourable, with low toxicity and good tolerance.

View Article and Find Full Text PDF

Unlike other mammals, bats serve as natural reservoirs for several highly pathogenic viruses without exhibiting symptoms of infection. Recent research has explored the complex mechanisms underlying the balance between bats' antiviral defenses and their pathological responses. However, the evolution of the molecular drivers behind bats' antiviral strategies remains largely unknown.

View Article and Find Full Text PDF

Type 1 Diabetes Mellitus (T1D) is an autoimmune disease caused by unremitting immune attack on pancreas insulin-producing beta cells. Persistence of the autoimmune response is mediated by TCF1+ Ly108+ progenitor CD8+ T (T) cells, a stem-like population that gives rise to exhausted effectors with limited cytolytic function in chronic virus infection and cancer. What paradoxically drives T conversion to highly cytolytic effectors in T1D, however, remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • High-dose methotrexate (MTX) can lead to serious complications like acute kidney injury (AKI), neutropenia, and liver damage, but glucarpidase, an enzyme that breaks down MTX, shows potential benefits.
  • In a study of 708 patients with MTX-AKI across 28 cancer centers, those receiving glucarpidase had a significantly higher chance of kidney recovery and faster recovery times compared to those who did not receive the treatment.
  • Additionally, glucarpidase treatment was associated with lower rates of severe neutropenia and liver enzyme elevation, but there was no notable difference in mortality rates between the two groups.
View Article and Find Full Text PDF